Back
TISCO Financial Group PCL Vs. Monopar Therapeutics Industry Stock Comparison
Sell
36
TSCFY
TISCO Financial Group PCL
Last Price:
$26.00
Seasonality Move:
9.79%
Buy
73
MNPR
Monopar Therapeutics
Last Price:
$39.20
Seasonality Move:
-13.19%
Sell
36
TISCO Financial Group PCL (TSCFY)
is a Sell
Is TISCO Financial Group PCL a Buy, Sell or Hold?
-
The current TISCO Financial Group PCL [TSCFY] share price is $26.00. The Score for TSCFY is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
-
TSCFY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
73
Monopar Therapeutics (MNPR)
is a Buy
Is Monopar Therapeutics a Buy, Sell or Hold?
-
The current Monopar Therapeutics [MNPR] share price is $33.67. The Score for MNPR is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.
-
MNPR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
TSCFY Stock Price Chart
What is TISCO Financial Group PCL's stock price today?
-
The TISCO Financial Group PCL share price today is $26.00The current trend is relatively stagnant and TSCFY is experiencing slight buying pressure.
MNPR Stock Price Chart
What is Monopar Therapeutics's stock price today?
-
The Monopar Therapeutics share price today is $33.67Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MNPR is experiencing slight buying pressure.
TSCFY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.03 | Sell |
Relative Strength Index (14 RSI): | 46.77 | Sell |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (26 - 26) | Sell |
Bollinger Bands (100): | (25.12 - 26.66) | Buy |
MNPR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.22 | Buy |
Relative Strength Index (14 RSI): | 68.66 | Buy |
Chaikin Money Flow: | 9701 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (22.89 - 29.07) | Buy |
Bollinger Bands (100): | (5.55 - 24.57) | Buy |
TSCFY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 26 | Sell |
20-day SMA: | 26 | Sell |
50-day SMA: | 26.17 | Sell |
200-day SMA: | 25.8 | Buy |
8-day EMA: | 26 | Sell |
20-day EMA: | 26.02 | Sell |
50-day EMA: | 26.03 | Sell |
200-day EMA: | 26.23 | Sell |
MNPR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 28.41 | Buy |
20-day SMA: | 25.66 | Buy |
50-day SMA: | 23.12 | Buy |
200-day SMA: | 9.21 | Buy |
8-day EMA: | 29.2 | Buy |
20-day EMA: | 26.65 | Buy |
50-day EMA: | 22.7 | Buy |
200-day EMA: | 12.39 | Buy |
TISCO Financial Group PCL Earnings Growth & TSCFY Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Monopar Therapeutics Earnings Growth & MNPR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.45 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.88 per share, and an increase next year of $2.41 per share.
TISCO Financial Group PCL Technical Analysis
Jan 7 | Jan 8 | Jan 10 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | Jan 17 | Jan 21 | Jan 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | ||||||||||
07 | 08 | 10 | 13 | 14 | 15 | 16 | 17 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Monopar Therapeutics Technical Analysis
Jan 7 | Jan 8 | Jan 10 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | Jan 17 | Jan 21 | Jan 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | ||||||||||
07 | 08 | 10 | 13 | 14 | 15 | 16 | 17 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |